SUMO-1 modification regulates the protein stability of the large regulatory protein Rep78 of adeno associated virus type 2 (AAV-2). (Q45140214)

10 December 2017

SUMO-1 modification regulates the protein stability of the large regulatory protein Rep78 of adeno associated virus type 2 (AAV-2). (English)

1 reference

10 December 2017

Stefan Weger

1

1 reference

10 December 2017

Eva Hammer

series ordinal

2

1 reference

10 December 2017

Regine Heilbronn

series ordinal

3

1 reference

10 December 2017

language of work or name

English

0 references

publication date

1 December 2004

1 reference

10 December 2017

1 reference

10 December 2017

330

1 reference

10 December 2017

1

1 reference

10 December 2017

284-294

1 reference

The cryptic life style of adeno-associated virus

10 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

Organization of the adeno-associated virus (AAV) capsid gene: mapping of a minor spliced mRNA coding for virus capsid protein 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

Posttranslational modification of TEL and TEL/AML1 by SUMO-1 and cell-cycle-dependent assembly into nuclear bodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

Inhibition of PrKX, a novel protein kinase, and the cyclic AMP-dependent protein kinase PKA by the regulatory proteins of adeno-associated virus type 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

Phosphorylation of the adeno-associated virus replication proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

High mobility group chromosomal protein 1 binds to the adeno-associated virus replication protein (Rep) and promotes Rep-mediated site-specific cleavage of DNA, ATPase activity and transcriptional repression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

PKA/PrKX activity is a modulator of AAV/adenovirus interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

Differential regulation of sentrinized proteins by a novel sentrin-specific protease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

Modulation of ETS-1 transcriptional activity by huUBC9, a ubiquitin-conjugating enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

Rep68 protein of adeno-associated virus type 2 interacts with 14-3-3 proteins depending on phosphorylation at serine 535.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

Protein modification by SUMO

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

The adeno-associated virus Rep78 major regulatory protein binds the cellular TATA-binding protein in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

The AAV origin binding protein Rep68 is an ATP-dependent site-specific endonuclease with DNA helicase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

Ubc9p is the conjugating enzyme for the ubiquitin-like protein Smt3p

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

An E3-like factor that promotes SUMO conjugation to the yeast septins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

The polycomb protein Pc2 is a SUMO E3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

Involvement of PIAS1 in the sumoylation of tumor suppressor p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

Covalent modification of the homeodomain-interacting protein kinase 2 (HIPK2) by the ubiquitin-like protein SUMO-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

A new SUMO-1-specific protease, SUSP1, that is highly expressed in reproductive organs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

DNA helicase-mediated packaging of adeno-associated virus type 2 genomes into preformed capsids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

Ubc9 interacts with a nuclear localization signal and mediates nuclear localization of the paired-like homeobox protein Vsx-1 independent of SUMO-1 modification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

Molecular characterization of the SUMO-1 modification of RanGAP1 and its role in nuclear envelope association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

SUMO--nonclassical ubiquitin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

SUMO, ubiquitin's mysterious cousin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

Hyper-phosphorylation of the adeno-associated virus Rep78 protein inhibits terminal repeat binding and helicase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

A novel mammalian Smt3-specific isopeptidase 1 (SMT3IP1) localized in the nucleolus at interphase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

The nucleoporin RanBP2 has SUMO1 E3 ligase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

Ubc9 interacts with the androgen receptor and activates receptor-dependent transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

SUMO-1 modification activates the transcriptional response of p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

SUMO-1 modification represses Sp3 transcriptional activation and modulates its subnuclear localization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

Adeno-associated virus: integration at a specific chromosomal locus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

Transcription factor Sp3 is silenced through SUMO modification by PIAS1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

The ubiquitin-like proteins SMT3 and SUMO-1 are conjugated by the UBC9 E2 enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

Crystal structure of murine/human Ubc9 provides insight into the variability of the ubiquitin-conjugating system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

Topors, a p53 and topoisomerase I binding protein, interacts with the adeno-associated virus (AAV-2) Rep78/68 proteins and enhances AAV-2 gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

The DNA topoisomerase I binding protein topors as a novel cellular target for SUMO-1 modification: characterization of domains necessary for subcellular localization and sumolation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

Role for highly regulated rep gene expression in adeno-associated virus vector production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

Adeno-associated virus Rep78 protein and terminal repeats enhance integration of DNA sequences into the cellular genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

7 January 2021

Genetics of adeno-associated virus: isolation and preliminary characterization of adeno-associated virus type 2 mutants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

7 January 2021

The cellular transcription factor SP1 and an unknown cellular protein are required to mediate Rep protein activation of the adeno-associated virus p19 promoter.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

7 January 2021

The adeno-associated virus (AAV) Rep protein acts as both a repressor and an activator to regulate AAV transcription during a productive infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

7 January 2021

Nucleotide sequence and organization of the adeno-associated virus 2 genome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

7 January 2021

Regulation of adeno-associated virus gene expression in 293 cells: control of mRNA abundance and translation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.028

7 January 2021

10.1016/J.VIROL.2004.09.028

Identifiers

DOI

1 reference

10 December 2017

1 reference